Trading Systems blogs
Home  
 
 
  Previous 10 Posts
  - Pershing Expected To Raise Stake In McDonald's
  - Chicago Merc Seen As Tops In Financial Exchanges
  - Royal Caribbean Expands With Spanish Acquisition
  - Gap Seen As Long-Term Opportunity
  - Analyst: Quest Diagnostics No Longer Undervalued
  - Schlumberger Shares Seen As Attractive
  - More Subpoenas Spur Sell-Off Of Take-Two
  - NASA Gives Lockheed A Boost
  - Vodafone Concentrating On Core Operations: Analyst
  - Costco Wholesale Rated 'Buy'
   

 
Categories


Stock market
Stock Trading articles
Trading Blogs
Best of ...
Elite Traders
Elite Traders#2
Technical trading blogs
Day trading blogs
   

 
Archives

News for July, 2006

News for May, 2006

News for April, 2006

News for March, 2006

News for February, 2006

News for January, 2006

   
 

Equity curve for Trading System no2.

382% Model portfolio performance for 2005!

Please note that all the content is copywritted by the original Blog's author!


Archives

1 2 3 4 6 7 8 9 10 11 12 
   
  - Is It Time to Buy IAC/InterActiveCorp?
at 2006-03-09 21:54:01
Barron's reports that IAC/InterActiveCorp (IACI) shares trade at a considerably lower multiple of both revenue and earnings than Google (GOOG), Amazon (AMZN), eBay (EBAY), or Yahoo! (YHOO) and, despite its complex structure, IACI may be a bargain once the numbers are crunched...(Read More

Source - http://www.schaeffersresearch.com/commentary/dailycontrarian.aspx?c=dcfeed&newsI...

  - McDonald's Sales Seen Beefing Up In Europe
at 2006-03-09 21:54:01

Prudential Equity Group maintained an "overweight" on the fast-food company.
Source - http://www.forbes.com/markets/2006/03/09/mcdonalds-europe-0309markets18.html?pa...

  - Fairchild's Higher Revenue Outlook
at 2006-03-09 21:54:02

S&P Equity Research raised 2006 and 2007 earnings estimates on shares of the chipmaker.
Source - http://www.forbes.com/markets/2006/03/09/fairchild-semiconductor-0309markets17....

  - Tysabri May See Approval Delayed By FDA
at 2006-03-09 21:54:02

Piper Jaffray maintained a "market perform" rating and $14 price target on Irish drugmaker Elan.
Source - http://www.forbes.com/markets/2006/03/09/elan-tysabri-0309markets16.html?partne...

  - ViroPharma's Sales Estimates Still 'Highly Conservative'
at 2006-03-09 21:54:02

Piper Jaffray maintained an "outperform" rating and $24 price target on the biotech stock.
Source - http://www.forbes.com/markets/2006/03/09/viropharma-vancocin-0309markets15.html...

   
1 2 3 4 6 7 8 9 10 11 12 

Last 10 Posts
   
  - Tom Cruise Couldn't Show Viacom the Money

  - Rob Black's Media Stock Report

  - IMAX Accounting and Legal Woes Make It a Sell

  - Lionsgate Films: Decent Company, But Not Worth the Margin Exposure

  - Rob Black's Media Stock Report

  - CBS Holds Hidden Value

  - Imax: How to Ruin a Great Company

  - CBS's CEO Proves "Les is More"

  - E.W. Scripps Company: An Unconventional Bursting Housing Bubble Play

  - TiVo's Ballooning Subscriber Acquisition Costs

   

Home| Members Only | Trading Articles | Subscribe | FAQ | Disclaimer | Privacy policy